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Summary
Background: Gene expression profiles of several tumor suppressor genes are regulated by the 
methylation and demethylation of their promoters. Here, we aim to identify and quantify the 
methylation status of four tumor suppressor genes from placentas at term and compare them 
with the maternal white-blood-cells. 
Methods: In order to achieve this objective, DNA enriched from twenty placentas at term and 
maternal white blood cells was bisulfite-converted and amplified using quantitative real-time 
methyl-light polymerase chain reaction for the four-genes studied (RASSF1A, APC, RAR-beta, 
and PTGS2).
Results: Among the four genes examined, RASSF1A, APC and RAR-beta promoter regions were 
hypermethylated in all the placental samples compared with maternal WBCs. Strikingly, PTGS2 
was found to be hypomethylated in the placentas compared to the maternal cells.
Conclusion: Since placental DNA represents fetal methylation profile and it is an established 
fact that there is certain amount of cell free circulating DNA in human plasma/serum, these 
data strongly suggest that hypermethylation of RASSF1A, APC and RAR-beta can be used as 
gender independent biomarkers to distinctly identify placental DNA in maternal blood. In-
addition, this is the first report which demonstrates hypomethylation of PTGS2 locus which 
may have important clinical implications e.g. placental abnormalities.
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Introduction
DNA methylation patterns change during initiation and progression of can-
cer, leading to alterations in the gene expression profiles of a variety of relevant 
genes, e.g., those involved in regulating cellular proliferation, invasion and migra-
tion (Esteller, 2007). There is striking similarity between placental development and 
tumor growth. Thus in order to assess the role of DNA methylation in normal and 
abnormal placental development the focus has been on genes related to develop-
ment of tumors.
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One of the earliest investigations to examine the methylation status of some can-
didate tumor suppressor genes in the placenta was performed by Chiu et al. (2007). 
They discovered hypermethylation of the RASSF1A gene in term placentas, whereas 
this gene target was not hypermethylated in any maternal white blood cell (WBC) 
samples. Hypermethylation of gene promoters leads to changes in gene expression 
and may contribute to placental pathologies (e.g., preeclampsia). Herein we have 
identified and quantified the methylation status of four tumour suppressor genes 
from placentas at term and compare them with the maternal WBCs.
Materials and Methods
Sample collection
Placental and peripheral blood samples were collected from 20 women admit-
ted for delivery at the Aga Khan University Hospital for uncomplicated pregnancies 
at gestational age > 37 weeks. Peripheral blood samples were collected before the 
onset of labor from the same women from whom placental samples were acquired. 
The study and the method for collecting human clinical samples were approved by 
the Aga Khan University Ethics Review Committee. Written informed consent was 
obtained from all the participants prior to collection of the samples. 
DNA extraction 
DNA was extracted using Tissue DNA extraction kit (Qiagen, Maiz, Germany) 
from 1 cm3 piece of placental tissue dissected from the fetal surface, near the umbil-
ical cord. Concurrently DNA was also extracted from a 5 ml maternal blood sample 
using QIAamp® Blood Mini Kit (Qiagen, Mainz, Germany) according to the “blood 
and body fluid protocol”. A totally methylated DNA served as a positive control.
Bisulphite modification and quantitative-methylation specific real-time PCR
3 µg of extracted DNA from the placenta and the leukocytes was bisulfite convert-
ed using the Methyl Easy Xceed DNA Modification Kit (Human Genetic Signatures 
Pty, Sydney, Australia). A bisulphite converted totally methylated DNA was used as 
a positive control. Real-time PCR was established for four genes, namely, APC, RASS-
F1A, RAR-β and PTGS2.
β-ACTIN was used as an internal control to detect the presence of total DNA. 
Real-time quantitative PCR analysis was performed using Chromo4 Real-time PCR 
Detector (Bio-Rad, Hercules, CA). All experiments were performed in a reaction vol-
ume of 25 µl with 2 µl bisulphite converted DNA with the following reaction condi-
tions: 1X Go flexi buffer, 5.5 mM MgCl2, 0.2 mM of each dNTPs, 450 nM of forward 
and 450 nM of reverse primers, 125 nM of TaqMan probe and 1 U of Go Flexi Taq 
Polymerase (all from Promega, Fitchburg, WI). Cycling conditions were 5 min ini-
tial denaturation at 95 °C, 55 cycles of 15 s denaturation at 95 °C, 1 min annealing 
and extension at 60 °C and fluorescence detection at the end of each cycle. Methyl-
ated DNA served a positive control. Blank reaction with water substituted for DNA 
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served as negative control. A five-point standard curve for each gene was prepared 
using serial dilutions of 3 µg of bisulfite converted methylated DNA. All primers and 
probes were obtained from Biosearch Technologies (Novato, CA). Primer and probe 
sequences used were previously described by (Eads et al., 2001; Fackler et al., 2004; 
Yegnasubramanian et al., 2004) and presented in Table 1.
Statistical analysis
To quantify the relative proportion of methylation at the candidate gene loci in 
all the samples (placental and maternal), a methylation index was determined for 
each gene in each tissue sample. The methylation index was defined as the ratio of 
the normalized (normalized to positive control, totally methylated DNA) amount of 
methylated templates at the promoter region of interest to the normalized amounts 
of converted beta actin (ACTB) templates in a given sample. These ACTB template do 
not have CpG sequences so they are unaffected by bisulphite conversion.
In order to assess the statistical significance in the methylation status of each gene 
locus between maternal WBC and placental samples, non-parametric Mann-Whitney 
test was employed. All analyses were conducted using SPSS (Chicago, IL) software 
Version 16.0.
Results
In this report we have compared the methylation status of four tumour suppres-
sor genes (RASSF1A, APC, RAR-β and PTGS2) in 20 maternal WBC samples with 
20 placental samples obtained from the same patients using methyl-light technolo-
gy. In order to quantify the methylation status at each gene locus a standard curve 
Table 1 – Primers and Probe Sequences.
Gene symbol 5′ to 3′ Forward primer 5′ to 3′ Taqman probe 5′ to 3′ Reverse primer
RASSF1A GCGTTGAAGTCGGGG TTC
FAM-ACAAACGCGAA 
CCGAACGAAACCA-
BHQ1
CCCGTACTTCGCTAACT 
TTAAACG
PTGS2 CGGAAGCGTTCGGG TAAAG
FAM-TTTCCGCCAAAT 
ATCTTTTCTTCTTCGCA-
BHQ1
AATTCCACCGCCCCAA 
AC
RAR-β
AGAACGCGAGCGATT 
CGAGTAG
FAM-ATCCTACCCCG 
ACG ATACCCAAAC-
BHQ1
TACAAAAAACCTTCC 
GAATACGTT
APC TTATATGTCGGTTACGT GCGTTTATAT
FAM-CCCGTCGAAAAC-
CCGCCGATTA-BHQ1
GAACCAAAACGCTCCC 
CAT
ACTB TGGTGATGGAGGAGGT TTAGTAAGT
FAM-ACCACCAC-
CCAACACACAATA 
ACAAACACA-BHQ1
AACCAATAAAACCTAC 
TCCTCCCTTAA
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was developed using dilutions of methylated DNA. The r2 value for all the stan-
dard-curves was -0.99. 
The results are summarized in Tables 2 and 3. RASSF1A and APC were found to 
be hypermethylated in all the placental samples while none of the maternal WBC 
samples showed methylation at these gene loci. RAR-β was found to be partially 
methylated in the placenta and maternal samples. However, the level of methylation 
was considered to be significantly higher (p<0.001) in placental samples compared 
to maternal WBC controls as shown by methylation index values. PTGS2 gene locus 
also showed differential methylation levels in term placentas and maternal WBC 
samples; however this locus had a significantly lower methylation in the placental 
derived DNA as compared to maternal WBC samples. 
Discussion
Differences in the DNA methylation profiles of maternal and fetal DNA has made 
detection of cell free circulating DNA in the maternal blood a powerful non-invasive 
method for prenatal diagnosis (Nygren et al., 2010). Although the hypermethylation 
of RASSF1A, APC and RAR-beta in human placenta has been reported previously 
Table 2 – Cycle threshold (†) values in the placenta (n=20) and maternal cells (n=20).
Genes Placenta Maternal Cells Methylated DNA*
Mean St.dev Range Mean St.dev Range Mean
Actin 23.3 1.1 4.9 23.6 1.4 0.00 22.6
RASSF1A 22.6 3.3 12.9 0.00 0.00 0.00 22.5
APC 24.7 1.0 3.7 0.00 0.00 0.00 21.9
RAR-β 23.7 2.1 7.2 30.7 1.8 0.00 23.6
PTGS2 32.7 2.0 7.5 29.7 2.2 0.00 23.7
*Methylated DNA is artificially converted totally methylated DNA.
† Cycle threshold is the cycle number at which a sufficient number of copies has been made from template 
DNA while performing a polymerase chain reaction (PCR). In quantitative PCR (Q-PCR) this cycle number is 
related with enough fluorescence to be detected.
Table 3 – Methylation Index (MI).
Genes MI values in placenta MI values in maternal leukocytes
RASSF1A 1.0 0.00
APC 0.2 0.00
RAR-β 1.0 0.01
PTGS2 0.003 0.03
The MI was standardized based on the gene concentration found in the methylated DNA (=1.0).
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(Chiu et al., 2007; Novakovic et al., 2008), since DNA methylomes are population 
specific the current study describes for the first time these changes in Pakistani pop-
ulation. 
DNA methylation plays an important role in placental development as evidenced 
from studies using the demethylating agent 5-Aza-2-deoxycytosine (5-deoxy-Aza). 
Administration of 5-deoxy-Aza to pregnant rats during different stages of placental 
development disrupted trophoblast proliferation (Serman et al., 2007; Vlahovic et al., 
1999). Further, 5-deoxy-Aza inhibited migration of choriocarcinoma cell lines (Rahna-
ma et al., 2006), suggesting a role of DNA methylation in migration and invasion of 
trophoblast cells. 
Placenta share many similarities with cancer such as trophoblast proliferation and 
migration and neo-vascularization. In this context, it has been shown recently that 
the promoters of several tumour suppressor genes get hypermethylated in placenta 
including those of RASSF1A, APC and Maspin (Chiu et al., 2007; Dokras et al., 2006; 
Wong et al., 2008). Hypermethylation of RASSF1A and APC noted in our study is 
consistent with previous studies. Further, we noted hypermethylation of RAR-β gene 
which is a repressor of Wnt signaling pathway. A previous study has shown that four 
genes which negatively regulate Wnt signaling pathway are hypermethylated in term 
placentas (Novakovic et al., 2008).
Herein, we are reporting for the first time hypomethylation of the gene locus 
PTGS2 (Cox2). This finding might have important implications to placental abnormal-
ities like preeclampsia. A previous report indicated that PTGS2 expression increases 
in placentas derived from pre-eclamptic women and is correlated with increased lev-
els of Cox2 products, prostaglandin and thromboxane-A2. Further, that study showed 
that there was infiltration of leukocytes in vascular smooth muscle and vasoconstric-
tion presumably contributing to preeclampsia (Walsh and Shah, 2007).
One of the major problem faced by many investigators is this area is to correlate 
the methylation status of the gene loci with the expression profile of these genes. 
There is significant difference between methylation status and expression profiles of 
genes because of two reasons 1) site to site variability of sample taken from placenta 
2) rapid degradation of mRNA post-delivery in human placenta (Avila et al., 2010).
Nevertheless, tumour suppressor genes presumably play a significant role in pla-
cental development. Aberrant methylation pattern may be responsible for placental 
pathologies such as preeclampsia, intrauterine growth retardation, placental abrup-
tion and ischemia. Thus further work is warranted to compare the methylation status 
of these genes in the placenta of normal and abnormal pregnancies. In addition, the 
detection of differential methylation profiles in the DNA extracted from plasma sam-
ples of patients with abnormal pregnancies can be used as a predictive tool to detect 
abnormality early in pregnancy.
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